Published in J Acquir Immune Defic Syndr on October 01, 2015
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS (2003) 11.66
Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J Immunol Methods (1989) 3.39
Sensitive detection and early prognostic significance of p24 antigen in heat-denatured plasma of human immunodeficiency virus type 1-infected infants. Swiss Neonatal HIV Study Group. J Infect Dis (1994) 1.69
p24 Antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection. J Clin Microbiol (2003) 1.64
Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection. J Infect Dis (1999) 1.58
Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma. AIDS (1997) 1.50
Comparison of an assay using signal amplification of the heat-dissociated p24 antigen with the Roche Monitor human immunodeficiency virus RNA assay. J Clin Microbiol (2002) 1.43
A highly sensitive and dynamic immunofluorescent cytometric bead assay for the detection of HIV-1 p24. J Virol Methods (2009) 1.31
Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay. J Clin Microbiol (2005) 1.27
Nanoparticle-Based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen. J Acquir Immune Defic Syndr (2007) 1.27
HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 1.24
Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART. J Med Virol (2006) 1.19
Nanoparticle-based immunoassays for sensitive and early detection of HIV-1 capsid (p24) antigen. J Infect Dis (2010) 1.19
A novel and innovative quantitative kinetic software for virological colorimetric assays. J Virol Methods (1998) 1.19
Measuring proteins on microarrays. Curr Opin Biotechnol (2002) 1.18
Adaptation of the ultrasensitive HIV-1 p24 antigen assay to dried blood spot testing. J Acquir Immune Defic Syndr (2007) 1.14
Analytical sensitivity of four HIV combined antigen/antibody assays using the p24 WHO standard. J Clin Virol (2011) 1.03
Combination assay detecting both human immunodeficiency virus (HIV) p24 antigen and anti-HIV antibodies opens a second diagnostic window. J Clin Microbiol (2005) 0.98
Detection of HIV-1 p24 Gag in plasma by a nanoparticle-based bio-barcode-amplification method. Nanomedicine (Lond) (2008) 0.95
Immunomagnetic quantitative immuno-PCR for detection of less than one HIV-1 virion. J Virol Methods (2009) 0.94
Viral RNA and p24 antigen as markers of HIV disease and antiretroviral treatment success. Int Arch Allergy Immunol (2003) 0.93
Development of an enzyme-linked immunosorbent assay (ELISA) combined with a streptavidin-biotin and enzyme amplification method to detect anti-2,3-di-o-acyltrehalose (DAT) antibodies in patients with tuberculosis. J Immunol Methods (1994) 0.87
Single-molecule immunosorbent assay as a tool for human immunodeficiency virus-1 antigen detection. Anal Bioanal Chem (2009) 0.85
Detection of Amyloid-beta aggregates in body fluids: a suitable method for early diagnosis of Alzheimer's disease? Curr Alzheimer Res (2009) 0.84
From molecular diagnostics to personalized testing. Pharmacogenomics (2007) 0.80
Proof of principle: an HIV p24 microsphere immunoassay with potential application to HIV clinical diagnosis. Cytometry B Clin Cytom (2009) 0.79
Detection of HIV-1 p24 antigen in patients with varying degrees of viremia using an ELISA with a photochemical signal amplification system. Clin Chim Acta (2016) 0.77
Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways. J Biol Chem (2006) 1.26
A general approach for investigating enzymatic pathways and substrates for ubiquitin-like modifiers. Arch Biochem Biophys (2006) 0.98
FAT10 modifies p53 and upregulates its transcriptional activity. Arch Biochem Biophys (2011) 0.92
Protein scission by metal ion-ascorbate system. Protein J (2006) 0.76
Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein Assay. AAPS J (2015) 0.75